[Form 4] SEMPRA Insider Trading Activity

Rhea-AI Filing Summary

Kevin C. Sagara, a director of Sempra (ticker SRE), reported sales of common stock on 09/15/2025 executed under a pre-established Rule 10b5-1 trading plan. The Form 4 shows two bulk disposals: 11,640 shares sold at a weighted average price of $83.76 (actual prices ranged $83.37–$84.365) and 17,224 shares sold at a weighted average price of $84.51 (actual prices ranged $84.37–$85.20). After these transactions Mr. Sagara directly beneficially owned 15,475.07 shares. He also holds an indirect interest of 2,404.4654 shares through a 401(k) savings plan. The filing notes sales were pursuant to a written instruction and 10b5-1 plan established March 19, 2025, and provides that breakdowns by price are available on request.

Positive

• Sales executed under a documented Rule 10b5-1 plan, indicating pre-established trading instructions
• Filing provides weighted-average prices and price ranges, offering transparency about execution prices
• Form is signed by an authorized attorney-in-fact, meeting procedural signature requirements

Negative

• Director disposed of a substantial number of shares (11,640 and 17,224 shares), which reduces his direct holding
• Filing does not state percentage ownership of outstanding shares, limiting context on remaining stake size

Insights

Corporate Governance Expert

TL;DR: Director sold shares under a documented 10b5-1 plan; disclosure is routine and reduces signaling risk.

The disclosure documents that the director's sales were made under a Rule 10b5-1(c) plan, which provides an affirmative defense against insider trading claims if executed properly. The filing supplies weighted-average sale prices and ranges, and notes that itemized price-by-lot information will be provided on request, which supports transparency. Ownership remaining after the disposals is small in absolute share count but the filing does not provide percentage ownership relative to outstanding shares, so assessment of control or influence is limited by the information provided.

Securities Compliance Analyst

TL;DR: Transaction appears procedurally compliant; record includes required explanatory detail and signature by attorney-in-fact.

The Form 4 contains the reporting person’s relation to issuer (director), the earliest transaction date, transaction codes indicating sale under plan, weighted-average prices with disclosed ranges, and a clear statement that trades were pursuant to a 10b5-1 plan dated March 19, 2025. The signature by an attorney-in-fact is present. Missing from the filing is percentage ownership versus total outstanding shares, but that omission reflects the scope of Form 4, not noncompliance. Overall procedural elements required by Section 16 are present.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sagara Kevin C.

(Last) (First) (Middle)

488 8TH AVENUE

(Street)

SAN DIEGO CA 92101

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SEMPRA [ SRE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/15/2025		S(1)		11,640	D	$83.76(2)	32,699.07	D
Common Stock	09/15/2025		S(1)		17,224	D	$84.51(3)	15,475.07	D
Common Stock								2,404.4654	I	401(k) savings plan (9/12/2025)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares of common stock reflected in this Form 4 were sold in accordance with a written instruction and plan for trading securities established by Mr. Sagara on March 19, 2025 pursuant to Rule 10b5-1(c) under the Securities Exchange Act of 1934.

2. Weighted average of sale prices. Actual prices range from $83.37 to $84.365. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, Sempra or any security holder of Sempra.

3. Weighted average of sale prices. Actual prices range from $84.37 to $85.20. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, Sempra or any security holder of Sempra.

Remarks:

	KEVIN C. SAGARA BY: Lisa H. Abbot, Managing Attorney - Corporate and Securities of Sempra and Attorney-In-Fact	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Kevin C. Sagara report on the Form 4 for Sempra (SRE)?

The Form 4 reports that Mr. Sagara sold 11,640 and 17,224 shares of Sempra common stock on 09/15/2025 under a Rule 10b5-1 trading plan.

Were the sales executed under a Rule 10b5-1 plan?

Yes. The filing states the trades were made pursuant to a written instruction and plan established on March 19, 2025 under Rule 10b5-1(c).

What prices were the shares sold for?

The filing provides weighted-average prices: $83.76 (range $83.37–$84.365) for one lot and $84.51 (range $84.37–$85.20) for the other; itemized lot prices are available on request.

How many Sempra shares does Mr. Sagara own after the reported transactions?

After the reported sales he directly beneficially owned 15,475.07 shares and indirectly held 2,404.4654 shares through a 401(k) savings plan.

Who signed the Form 4 on behalf of Kevin C. Sagara?

The Form 4 was signed by Lisa H. Abbot, Managing Attorney - Corporate and Securities of Sempra, as attorney-in-fact on 09/15/2025.